Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemospan versus Voluven for perioperative hypotension during primary hip arthroplasty
2006-002514-35Phase 3Completed
- Sponsor
- Sangart
- Start
- Oct 2006
- Modality
- Albumin → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Hemospan in hypotension (2 arms), sponsored by Sangart. Primary endpoint: Total duration of hypotensive episodes. Started Oct 2006; status: completed.
02
Drugs
Hemospan
03
Conditions
hypotension
Beyond the preview
Go deeper on 2006-002514-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002514-35.